Jozef Madzo to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Jozef Madzo has written about Dose-Response Relationship, Drug.
Connection Strength
0.061
-
TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors. Cancer Res. 2021 10 01; 81(19):5089-5101.
Score: 0.037
-
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia. Invest New Drugs. 2015 Apr; 33(2):371-9.
Score: 0.024